At the Bench: Preclinical Rationale for Exploiting Nk Cells and Gamma Delta T Lymphocytes for the Treatment of High-Risk Leukemias
AuthID
P-006-J8Z
P-006-J8Z
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service